Grabbe S - Search Results

1

S2k-Leitlinie Merkelzellkarzinom (MZK, MCC, neuroendokrines Karzinom der Haut) - Update 2018.

Becker JC, Eigentler T, Frerich B, Gambichler T, Grabbe S, Höller U, Klumpp B, Loquai C, Krause-Bergmann A, Müller-Richter U, Pföhler C, Schneider-Burrus S, Stang A, Terheyden P, Ugurel S, Veith J, Mauch C. Becker JC, et al. Among authors: grabbe s. J Dtsch Dermatol Ges. 2019 May;17(5):562-577. doi: 10.1111/ddg.13841_g. J Dtsch Dermatol Ges. 2019. PMID: 31115985

2

[Value of sentinel node biopsy considering melanoma management as an example].

Loquai C, Riemann H, Grabbe S. Loquai C, et al. Among authors: grabbe s. Urologe A. 2005 Jun;44(6):625-9. doi: 10.1007/s00120-005-0825-5. Urologe A. 2005. PMID: 15891866 Review. German.

3

Safety of pegylated interferon-alpha-2a in adjuvant therapy of intermediate and high-risk melanomas.

Loquai C, Nashan D, Hensen P, Luger TA, Grabbe S, Sunderkötter C, Schiller M. Loquai C, et al. Among authors: grabbe s. Eur J Dermatol. 2008 Jan-Feb;18(1):29-35. doi: 10.1684/ejd.2008.0307. Epub 2007 Dec 18. Eur J Dermatol. 2008. PMID: 18086586

4

Quality of life in melanoma patients during adjuvant treatment with pegylated interferon-α2b: patients' and doctors' views.

Loquai C, Schmidtmann I, Beutel M, Sunderkötter C, Grabbe S, Schiller M, Nashan D. Loquai C, et al. Among authors: grabbe s. Eur J Dermatol. 2011 Nov-Dec;21(6):976-84. doi: 10.1684/ejd.2011.1514. Eur J Dermatol. 2011. PMID: 21896421

5

[Systemic therapy for malignant melanoma].

Rudolph BM, Groffik A, Stanger C, Loquai C, Grabbe S. Rudolph BM, et al. Among authors: grabbe s. Hautarzt. 2012 Nov;63(11):885-98. doi: 10.1007/s00105-012-2447-3. Hautarzt. 2012. PMID: 23114509 German.

6

Brief S2k guidelines--Merkel cell carcinoma.

Becker JC, Assaf C, Vordermark D, Reske SN, Hense J, Dettenborn T, Seitz O, Grabbe S. Becker JC, et al. Among authors: grabbe s. J Dtsch Dermatol Ges. 2013 Jun;11 Suppl 3:29-36, 31-8. doi: 10.1111/ddg.12015_6. J Dtsch Dermatol Ges. 2013. PMID: 23734895 No abstract available.

7

Brief S2k guidelines--Cutaneous squamous cell carcinoma.

Breuninger H, Eigentler T, Bootz F, Hauschild A, Kortmann RD, Wolff K, Stockfleth E, Szeimies RM, Rompel R, Garbe C, Grabbe S. Breuninger H, et al. Among authors: grabbe s. J Dtsch Dermatol Ges. 2013 Jun;11 Suppl 3:37-45, 39-47. doi: 10.1111/ddg.12015_7. J Dtsch Dermatol Ges. 2013. PMID: 23734897 No abstract available.

8

Serum S100B levels correlate with clinical benefit in a metastatic melanoma patient treated by CTLA-4 blockade: a case report.

Loquai C, Müller-Brenne T, Schadmand-Fischer S, Grabbe S. Loquai C, et al. Among authors: grabbe s. Onkologie. 2013;36(10):578-81. doi: 10.1159/000355159. Epub 2013 Sep 17. Onkologie. 2013. PMID: 24107912

9

Increased frequencies of CD11b(+) CD33(+) CD14(+) HLA-DR(low) myeloid-derived suppressor cells are an early event in melanoma patients.

Rudolph BM, Loquai C, Gerwe A, Bacher N, Steinbrink K, Grabbe S, Tuettenberg A. Rudolph BM, et al. Among authors: grabbe s. Exp Dermatol. 2014 Mar;23(3):202-4. doi: 10.1111/exd.12336. Exp Dermatol. 2014. PMID: 24495013

10

Prurigo nodularis as index symptom of (non-Hodgkin) lymphoma: ultrasound as a helpful diagnostic tool in dermatological disorders of unknown origin.

Schweda K, Hainz M, Loquai C, Grabbe S, Saloga J, Tuettenberg A. Schweda K, et al. Among authors: grabbe s. Int J Dermatol. 2015 Apr;54(4):462-4. doi: 10.1111/ijd.12022. Epub 2014 Apr 2. Int J Dermatol. 2015. PMID: 24697249 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

426 results

Search Page